- Home
- HHS vs DXR Comparison
HHS vs DXR Comparison
Compare HHS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- DXR
- Stock Information
- Founded
- HHS 1923
- DXR 1970
- Country
- HHS United States
- DXR United States
- Employees
- HHS N/A
- DXR N/A
- Industry
- HHS Advertising
- DXR Medical/Dental Instruments
- Sector
- HHS Consumer Discretionary
- DXR Health Care
- Exchange
- HHS Nasdaq
- DXR Nasdaq
- Market Cap
- HHS 37.0M
- DXR 36.4M
- IPO Year
- HHS N/A
- DXR N/A
- Fundamental
- Price
- HHS $4.52
- DXR $7.75
- Analyst Decision
- HHS
- DXR Strong Buy
- Analyst Count
- HHS 0
- DXR 1
- Target Price
- HHS N/A
- DXR $25.00
- AVG Volume (30 Days)
- HHS 20.2K
- DXR 4.8K
- Earning Date
- HHS 05-16-2025
- DXR 01-01-0001
- Dividend Yield
- HHS N/A
- DXR N/A
- EPS Growth
- HHS N/A
- DXR 86.16
- EPS
- HHS N/A
- DXR 0.11
- Revenue
- HHS $185,242,000.00
- DXR $119,714.00
- Revenue This Year
- HHS $6.54
- DXR N/A
- Revenue Next Year
- HHS N/A
- DXR N/A
- P/E Ratio
- HHS N/A
- DXR $70.84
- Revenue Growth
- HHS N/A
- DXR N/A
- 52 Week Low
- HHS $4.27
- DXR $6.55
- 52 Week High
- HHS $8.87
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- HHS 45.88
- DXR 51.69
- Support Level
- HHS $4.77
- DXR $7.13
- Resistance Level
- HHS $4.81
- DXR $7.74
- Average True Range (ATR)
- HHS 0.33
- DXR 0.33
- MACD
- HHS -0.02
- DXR 0.02
- Stochastic Oscillator
- HHS 23.17
- DXR 89.04
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.